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Background: Postnatal development of cerebral structure and function involves regional alteration of the neurochemical profile [1], which can 
reflect the degree of differentiation and be affected by psychopathological conditions and disorders of the central nervous system [2]. A recent 
study on the development of the mouse brain [3] reported 
alterations in NAA, Tau, total creatine and total glutamate 
plus glutamine (Glx) concentrations some brain regions. The 
present study investigated non-invasively the development of 
the full neurochemical profile in the frontal and occipital 
cortex of mice, using in vivo 1H NMR spectroscopy.  
 
Methods: Localised in vivo 1H NMR spectroscopy was 
performed on a 14.1 T, 26 cm VNMRS spectrometer (Varian, 
Magnex) using a home-built 14 mm diameter quadrature 
surface coil (used both for RF excitation and signal reception). 
Field homogeneity was adjusted by FASTMAP [4], and 1H 
NMR spectra were acquired from VOIs of 2.5 to 3.5 μL 
placed in frontal or occipital regions of the cortex of C57BL/6 
mice (10, 20 and 90 days old, under 1 to 2% isoflurane 
anaesthesia), using SPECIAL [5,6] with TE of 2.8 ms and TR 
of 4 s. Typically, spectra were acquired with 480 scans. 
Metabolite concentrations were estimated with LCModel [7], 
using corrections for water content [1], and data was 
compared with the two-way ANOVA followed by 
Bonferroni’s post-test. 
 
Results: Typical in vivo 1H NMR spectra acquired in the 
frontal cortex of mice at postnatal days P10, P20 and P90 are 
shown in figure 1. Similar spectra were obtained for the 
occipital cortex, where we observed identical modifications of 
the neurochemical profile, composed of 20 metabolites (figure 
2). As previously reported for the rat cortex [1], there was a 
clear increase in creatine (Cr), glutamine (Gln), glutamate 
(Glu), myo-inositol (Ins) and N-acetylaspartate (NAA), and 
decrease of taurine (Tau) and phosphoethanolamine (PE) 
during postnatal development of both frontal and occipital 
cortical regions in mice (figure 2). Furthermore, we observed 
a reduction of ascorbate concentration during development in 
both cortical regions studied. Being able to quantify the 
concentration of both Glu and Gln, we now show that Glu 
continuously increases during development, while Gln levels 
achieved the adult concentration at P20. On the other hand, 
Ins levels did not change from P10 to P20 but increased from 
P20 to P90. Tau content was maintained from P10 to P20 and 
was decreased in the cortical regions of the adult mouse. 
 
Conclusion: The present study reported the normal variations 
of the neurochemical profile in the frontal and occipital cortex 
of the mouse, which can be taken as basis for the future 
investigation of neurochemical defects upon development and 
differentiation of the cerebral cortex, particularly benefiting of 
a plethora of transgenic mouse models of pathologies. 
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